Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-In Park

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Sciences|June 10, 2023
MAPK-ERK PathwayJong-In Park
Frontiers in Cell and Developmental Biology|April 28, 2023
Editorial: The role of mortalin in biology and diseaseJong-In Park
Frontiers in Biology|July 8, 2014
Growth arrest signaling of the Raf/MEK/ERK pathway in cancerJong-In Park
Endocrinology and Metabolism (Seoul, Korea)|October 21, 2015
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In VivoDmytro Starenki, Jong In Park
Journal of Pediatric Oncology|March 26, 2016
Pediatric Medullary Thyroid CarcinomaDmytro Starenki, Jong-In Park
International Journal of Molecular Sciences|October 14, 2023
Tumor Cell Resistance to the Inhibition of BRAF and MEK1/2Wenjing Chen, Jong-In Park
Cellular Signalling|January 18, 2015
Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cellsMansi Karkhanis, Jong-In Park
The Journal of Clinical Endocrinology and Metabolism|March 20, 2013
Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivoDmytro Starenki, Jong-In Park
Seminars in Oncology|November 29, 2015
MEK1/2 Inhibitors: Molecular Activity and Resistance MechanismsPui-Kei Wu, Jong-In Park
Cancers|March 26, 2014
The Role of STAT3 in Thyroid CancerNadiya Sosonkina, Dmytro Starenki, Jong-In Park
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|June 10, 2023
MAPK-ERK PathwayJong-In Park
Frontiers in Cell and Developmental Biology|April 28, 2023
Editorial: The role of mortalin in biology and diseaseJong-In Park
Frontiers in Biology|July 8, 2014
Growth arrest signaling of the Raf/MEK/ERK pathway in cancerJong-In Park
Endocrinology and Metabolism (Seoul, Korea)|October 21, 2015
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In VivoDmytro Starenki, Jong In Park
Journal of Pediatric Oncology|March 26, 2016
Pediatric Medullary Thyroid CarcinomaDmytro Starenki, Jong-In Park
International Journal of Molecular Sciences|October 14, 2023
Tumor Cell Resistance to the Inhibition of BRAF and MEK1/2Wenjing Chen, Jong-In Park
Cellular Signalling|January 18, 2015
Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cellsMansi Karkhanis, Jong-In Park
The Journal of Clinical Endocrinology and Metabolism|March 20, 2013
Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivoDmytro Starenki, Jong-In Park
Seminars in Oncology|November 29, 2015
MEK1/2 Inhibitors: Molecular Activity and Resistance MechanismsPui-Kei Wu, Jong-In Park
Cancers|March 26, 2014
The Role of STAT3 in Thyroid CancerNadiya Sosonkina, Dmytro Starenki, Jong-In Park
Pageof 20